47
Blackstone Life Sciences VI L.P. updates its Form D — $6.3B sold
Fund raise update · Private equity / buyout · Closed · Offering $6.3B · Sold $6.3B · NEW YORK, NY · filed 2026-04-02
3(c)(7) — qualified purchasers
37
Blackstone Life Sciences VI L.P. updates its Form D — $1.79B sold
Fund raise update · Private equity / buyout · Open-ended · NEW YORK, NY · Form D/A filed 2025-04-23 · all Blackstone Life Sciences vehicles
$100M+ sold3(c)(7) — qualified purchasers
Why now — by persona
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
People on the filing
| John G. Finley | Officer of the General Partner of the GP |
| Elsa G. Gelin | Officer of the General Partner of the GP |
| Natacha G. Jamar | Officer of the General Partner of the GP |
| n/a BXLS VI L.L.C. | The General Partner of the GP |
| Julie Constable | Officer of the General Partner of the GP |
| Omar G. Rehman | Officer of the General Partner of the GP |
| Nentcho G. Nentchev | Officer of the General Partner of the GP |
| Nicholas G. Galakatos | Officer of the General Partner of the GP |
| Joseph Baratta | Officer of the General Partner of the GP |
| Christopher G. Striano | Officer of the General Partner of the GP |
| Eric G. Liaw | Officer of the General Partner of the GP |
| n/a Blackstone Life Sciences Associates VI L.P. | "General Partner of the Issuer (the ""GP"")" |
| Robert G. Liptak | Officer of the General Partner of the GP |
Signed by Julie Constable, Chief Compliance Officer.
Placement agents / sales compensation: Raymond James & Associates, Inc.; Raymond James Financial Services Inc.; Compass Group Global Advisors S.A.; Merrill Lynch, Pierce, Fenner & Smith Incorporated; iCapital Markets LLC; Morgan Stanley Smith Barney LLC
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
37
Blackstone Life Sciences VI L.P. updates its Form D — $3.62B sold
Fund raise update · Private equity / buyout · Open-ended · Offering Indefinite · Sold $3.62B · NEW YORK, NY · filed 2025-12-09
3(c)(7) — qualified purchasers
37
Blackstone Life Sciences VI L.P. updates its Form D — $3.29B sold
Fund raise update · Private equity / buyout · Open-ended · Offering Indefinite · Sold $3.29B · NEW YORK, NY · filed 2025-10-08
3(c)(7) — qualified purchasers
82
Blackstone Life Sciences VI L.P. files an open-ended private equity / buyout fund
New fund · Private equity / buyout · Pre-first close · Offering Indefinite · NEW YORK, NY · filed 2024-12-17
3(c)(7) — qualified purchasersPre-first closeFirst filing by this entity